SI2986308T1 - Angiotenzin II v kombinaciji za zdravljenje hipotenzije - Google Patents

Angiotenzin II v kombinaciji za zdravljenje hipotenzije

Info

Publication number
SI2986308T1
SI2986308T1 SI201431450T SI201431450T SI2986308T1 SI 2986308 T1 SI2986308 T1 SI 2986308T1 SI 201431450 T SI201431450 T SI 201431450T SI 201431450 T SI201431450 T SI 201431450T SI 2986308 T1 SI2986308 T1 SI 2986308T1
Authority
SI
Slovenia
Prior art keywords
hypotension
angiotensin
treatment
combination
Prior art date
Application number
SI201431450T
Other languages
English (en)
Inventor
Lakhmir Chawla
Original Assignee
The George Washington University, A Congressionally Chartered Not-For-Profit Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2986308(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The George Washington University, A Congressionally Chartered Not-For-Profit Corporation filed Critical The George Washington University, A Congressionally Chartered Not-For-Profit Corporation
Publication of SI2986308T1 publication Critical patent/SI2986308T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SI201431450T 2013-12-18 2014-12-18 Angiotenzin II v kombinaciji za zdravljenje hipotenzije SI2986308T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US201461955706P 2014-03-19 2014-03-19
EP14872684.7A EP2986308B1 (en) 2013-12-18 2014-12-18 Angiotensin ii in combination for the treatment of hypotension
PCT/US2014/071186 WO2015095535A1 (en) 2013-12-18 2014-12-18 Angiotensin ii alone or in combination for the treatment of hypotension

Publications (1)

Publication Number Publication Date
SI2986308T1 true SI2986308T1 (sl) 2020-03-31

Family

ID=53367119

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431450T SI2986308T1 (sl) 2013-12-18 2014-12-18 Angiotenzin II v kombinaciji za zdravljenje hipotenzije

Country Status (23)

Country Link
US (7) US9220745B2 (sl)
EP (2) EP3607962A1 (sl)
JP (3) JP6824739B2 (sl)
KR (3) KR20220028125A (sl)
CN (3) CN106061493A (sl)
AU (2) AU2014364528C1 (sl)
BR (1) BR112016013961A2 (sl)
CA (1) CA2933601A1 (sl)
CY (1) CY1122604T1 (sl)
DK (1) DK2986308T3 (sl)
EA (1) EA037823B1 (sl)
ES (1) ES2771749T3 (sl)
HR (1) HRP20200009T1 (sl)
HU (1) HUE047062T2 (sl)
IL (1) IL246162B (sl)
LT (1) LT2986308T (sl)
MX (2) MX2016008108A (sl)
NZ (1) NZ721089A (sl)
PL (1) PL2986308T3 (sl)
PT (1) PT2986308T (sl)
RS (1) RS59804B1 (sl)
SI (1) SI2986308T1 (sl)
WO (1) WO2015095535A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
EP3607962A1 (en) 2013-12-18 2020-02-12 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensin ii alone or in combination for the treatment of hypotension
TW202214219A (zh) * 2014-07-08 2022-04-16 美商拉荷亞製藥公司 治療低血壓之方法
US9919022B2 (en) 2015-03-20 2018-03-20 Arthur J. ATKINSON, JR. Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
EP3400000B1 (en) 2016-01-07 2023-12-06 La Jolla Pharma, LLC Methods for administering angiotensin ii
CA3010788A1 (en) * 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
WO2023244552A1 (en) * 2022-06-15 2023-12-21 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
US6592865B2 (en) 2001-06-04 2003-07-15 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
JP2007510643A (ja) 2003-11-06 2007-04-26 ジーイー・ヘルスケア・アクスイェ・セルスカプ 医薬化合物
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
WO2007040636A1 (en) 2005-09-29 2007-04-12 Fibrogen, Inc. Methods for reducing blood pressure
US20090304818A1 (en) 2005-12-30 2009-12-10 May Clive N Method of treatment
WO2007146900A2 (en) 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
BRPI0719319A2 (pt) 2006-11-17 2014-02-04 Da Volterra Liberação colônica usando contas de zn/pectina com um revestimento de eudragit
WO2009009907A1 (en) 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
CN102301235B (zh) 2008-11-28 2014-11-19 Abbvie公司 稳定的抗体组合物和用于稳定其的方法
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
BR112013000744A2 (pt) 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ 腎不全を処置するための組成物及び方法
EP3607962A1 (en) 2013-12-18 2020-02-12 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensin ii alone or in combination for the treatment of hypotension
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
TW202214219A (zh) * 2014-07-08 2022-04-16 美商拉荷亞製藥公司 治療低血壓之方法
CA3010788A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
EP3400000B1 (en) 2016-01-07 2023-12-06 La Jolla Pharma, LLC Methods for administering angiotensin ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法

Also Published As

Publication number Publication date
DK2986308T3 (en) 2020-01-27
WO2015095535A1 (en) 2015-06-25
EP2986308A1 (en) 2016-02-24
RS59804B1 (sr) 2020-02-28
CN112546197A (zh) 2021-03-26
AU2014364528C1 (en) 2021-01-07
IL246162A0 (en) 2016-07-31
WO2015095535A9 (en) 2016-07-14
CA2933601A1 (en) 2015-06-25
AU2014364528A1 (en) 2016-06-30
CY1122604T1 (el) 2021-03-12
US10493124B2 (en) 2019-12-03
KR20160117437A (ko) 2016-10-10
US11096983B2 (en) 2021-08-24
US20160129072A1 (en) 2016-05-12
US20190070250A1 (en) 2019-03-07
US20220047669A1 (en) 2022-02-17
BR112016013961A2 (pt) 2017-10-10
EP3607962A1 (en) 2020-02-12
JP7175506B2 (ja) 2022-11-21
US20190328827A1 (en) 2019-10-31
AU2014364528A9 (en) 2016-07-28
EA037823B1 (ru) 2021-05-25
AU2020277230A1 (en) 2020-12-24
US20180193407A1 (en) 2018-07-12
US20230226141A1 (en) 2023-07-20
JP2019214610A (ja) 2019-12-19
MX2016008108A (es) 2017-03-09
NZ721089A (en) 2022-10-28
US11559559B2 (en) 2023-01-24
ES2771749T3 (es) 2020-07-07
KR20230051721A (ko) 2023-04-18
KR102399383B1 (ko) 2022-05-19
JP2017501154A (ja) 2017-01-12
AU2014364528B2 (en) 2020-08-27
MX2020011190A (es) 2020-11-13
LT2986308T (lt) 2020-03-25
PL2986308T3 (pl) 2020-05-18
CN106061493A (zh) 2016-10-26
HUE047062T2 (hu) 2020-04-28
EA201691258A1 (ru) 2016-11-30
CN111920939A (zh) 2020-11-13
US9220745B2 (en) 2015-12-29
PT2986308T (pt) 2020-01-21
US20150164980A1 (en) 2015-06-18
JP2022137224A (ja) 2022-09-21
HRP20200009T1 (hr) 2020-03-20
JP6824739B2 (ja) 2021-02-03
IL246162B (en) 2020-03-31
EP2986308B1 (en) 2019-10-16
US10028995B2 (en) 2018-07-24
KR20220028125A (ko) 2022-03-08
US10765722B2 (en) 2020-09-08
EP2986308A4 (en) 2017-01-11

Similar Documents

Publication Publication Date Title
GB201321746D0 (en) Therapeutic agents
GB201321743D0 (en) Therapeutic agents
GB201321736D0 (en) Therapeutic agents
GB201321738D0 (en) Therapeutic Agents
GB201321729D0 (en) Therapeutic agents
GB201321728D0 (en) Therapeutic agents
GB201321730D0 (en) Therapeutic agents
GB201321739D0 (en) Therapeutic agents
GB201321741D0 (en) Therapeutic agents
IL246162A0 (en) Angiotensin II, alone or in combination, to treat low blood pressure
GB201321740D0 (en) Therapeutic agents
GB201321732D0 (en) Therapeutic agents
GB201321734D0 (en) Therapeutic Agents
GB201321737D0 (en) Therapeutic Agents
GB201321744D0 (en) Therapeutic agents
GB201321742D0 (en) Therapeutic agents
GB201321735D0 (en) Therapeutic Agents
HK1215164A1 (zh) 處理方法
GB201321745D0 (en) Therapeutic agents
GB201304872D0 (en) Treatment
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
HK1216391A1 (zh) 組合治療
GB201302839D0 (en) Water Treatment
GB201307310D0 (en) Treatment
ZA201604412B (en) Water treatment